Halley E. Gilbert - 20 Nov 2025 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Reporting relationship: Director
Issuer ticker: ARQT
Reported as of: 20 Nov 2025
Net transaction value: -$363,670
SEC form: 4
Accepted by SEC: 21 Nov 2025, 18:21:26 UTC
Prior SEC filing: 16 Jun 2025
Next SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/Latha Vairavan, as Attorney-in-Fact for Halley E. Gilbert

Key filing fact

Halley E. Gilbert filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 21 Nov 2025.

Key facts

This page summarizes Halley E. Gilbert's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Nov 2025, 18:21.

Change

Previous filing in this sequence was filed on 16 Jun 2025.
Current net transaction value: -$363,670.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001601360 Primary reporting owner

Gilbert Halley E

Relationship: Director
Address: C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE
Signature: /s/Latha Vairavan, as Attorney-in-Fact for Halley E. Gilbert
Signature date: 21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARQT transaction

Common Stock

Options Exercise

Transaction value: $91,772
Shares: +12,220
Change %: +46%
Price: $7.51
Shares after: 38,655
Date: 20 Nov 2025
Ownership: Direct
Footnotes: F1

ARQT transaction

Common Stock

Sale

Transaction value: $455,442
Shares: -16,532
Change %: -43%
Price: $27.55
Shares after: 22,123
Date: 20 Nov 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARQT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -12,220
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 20 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,220
Exercise price: $7.51
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.

Footnote F2

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $27.32 to $27.72, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.